Clinical Trials Browser

Phase 2 × Carcinoma, Hepatocellular × Zoledronic Acid × Clear all

NCT01259193 2011-04-14

Clinical Study of Sorafenib and Zoledronic Acid to Treat Advanced HCC

Phase 2 Unknown

Gastrointestinal

Carcinoma, Hepatocellular